285 related articles for article (PubMed ID: 14985428)
1. Disease progression despite early loss of polyglutamine protein expression in SCA7 mouse model.
Helmlinger D; Abou-Sleymane G; Yvert G; Rousseau S; Weber C; Trottier Y; Mandel JL; Devys D
J Neurosci; 2004 Feb; 24(8):1881-7. PubMed ID: 14985428
[TBL] [Abstract][Full Text] [Related]
2. Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7.
La Spada AR; Fu YH; Sopher BL; Libby RT; Wang X; Li LY; Einum DD; Huang J; Possin DE; Smith AC; Martinez RA; Koszdin KL; Treuting PM; Ware CB; Hurley JB; Ptácek LJ; Chen S
Neuron; 2001 Sep; 31(6):913-27. PubMed ID: 11580893
[TBL] [Abstract][Full Text] [Related]
3. Reduction of mutant ataxin-7 expression restores motor function and prevents cerebellar synaptic reorganization in a conditional mouse model of SCA7.
Furrer SA; Waldherr SM; Mohanachandran MS; Baughn TD; Nguyen KT; Sopher BL; Damian VA; Garden GA; La Spada AR
Hum Mol Genet; 2013 Mar; 22(5):890-903. PubMed ID: 23197655
[TBL] [Abstract][Full Text] [Related]
4. Antisense oligonucleotides targeting mutant Ataxin-7 restore visual function in a mouse model of spinocerebellar ataxia type 7.
Niu C; Prakash TP; Kim A; Quach JL; Huryn LA; Yang Y; Lopez E; Jazayeri A; Hung G; Sopher BL; Brooks BP; Swayze EE; Bennett CF; La Spada AR
Sci Transl Med; 2018 Oct; 10(465):. PubMed ID: 30381411
[TBL] [Abstract][Full Text] [Related]
5. Spinocerebellar ataxia type 7 cerebellar disease requires the coordinated action of mutant ataxin-7 in neurons and glia, and displays non-cell-autonomous bergmann glia degeneration.
Furrer SA; Mohanachandran MS; Waldherr SM; Chang C; Damian VA; Sopher BL; Garden GA; La Spada AR
J Neurosci; 2011 Nov; 31(45):16269-78. PubMed ID: 22072678
[TBL] [Abstract][Full Text] [Related]
6. Interference of Crx-dependent transcription by ataxin-7 involves interaction between the glutamine regions and requires the ataxin-7 carboxy-terminal region for nuclear localization.
Chen S; Peng GH; Wang X; Smith AC; Grote SK; Sopher BL; La Spada AR
Hum Mol Genet; 2004 Jan; 13(1):53-67. PubMed ID: 14613968
[TBL] [Abstract][Full Text] [Related]
7. Hsp70 and Hsp40 chaperones do not modulate retinal phenotype in SCA7 mice.
Helmlinger D; Bonnet J; Mandel JL; Trottier Y; Devys D
J Biol Chem; 2004 Dec; 279(53):55969-77. PubMed ID: 15494410
[TBL] [Abstract][Full Text] [Related]
8. Comparative analyses of Purkinje cell gene expression profiles reveal shared molecular abnormalities in models of different polyglutamine diseases.
Friedrich B; Euler P; Ziegler R; Kuhn A; Landwehrmeyer BG; Luthi-Carter R; Weiller C; Hellwig S; Zucker B
Brain Res; 2012 Oct; 1481():37-48. PubMed ID: 22917585
[TBL] [Abstract][Full Text] [Related]
9. Progressive retinal degeneration and dysfunction in R6 Huntington's disease mice.
Helmlinger D; Yvert G; Picaud S; Merienne K; Sahel J; Mandel JL; Devys D
Hum Mol Genet; 2002 Dec; 11(26):3351-9. PubMed ID: 12471061
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration.
Garden GA; La Spada AR
Cerebellum; 2008; 7(2):138-49. PubMed ID: 18418675
[TBL] [Abstract][Full Text] [Related]
11. Expanded polyglutamines induce neurodegeneration and trans-neuronal alterations in cerebellum and retina of SCA7 transgenic mice.
Yvert G; Lindenberg KS; Picaud S; Landwehrmeyer GB; Sahel JA; Mandel JL
Hum Mol Genet; 2000 Oct; 9(17):2491-506. PubMed ID: 11030754
[TBL] [Abstract][Full Text] [Related]
12. Polyglutamine-expanded ataxin-7 inhibits STAGA histone acetyltransferase activity to produce retinal degeneration.
Palhan VB; Chen S; Peng GH; Tjernberg A; Gamper AM; Fan Y; Chait BT; La Spada AR; Roeder RG
Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8472-7. PubMed ID: 15932940
[TBL] [Abstract][Full Text] [Related]
13. Qs in the nucleus.
Orr HT
Neuron; 2001 Sep; 31(6):875-6. PubMed ID: 11580886
[TBL] [Abstract][Full Text] [Related]
14. Glutamine-expanded ataxin-7 alters TFTC/STAGA recruitment and chromatin structure leading to photoreceptor dysfunction.
Helmlinger D; Hardy S; Abou-Sleymane G; Eberlin A; Bowman AB; Gansmüller A; Picaud S; Zoghbi HY; Trottier Y; Tora L; Devys D
PLoS Biol; 2006 Mar; 4(3):e67. PubMed ID: 16494529
[TBL] [Abstract][Full Text] [Related]
15. Insights into the molecular basis of polyglutamine neurodegeneration from studies of a spinocerebellar ataxia type 7 mouse model.
Grote SK; La Spada AR
Cytogenet Genome Res; 2003; 100(1-4):164-74. PubMed ID: 14526177
[TBL] [Abstract][Full Text] [Related]
16. SCA7 knockin mice model human SCA7 and reveal gradual accumulation of mutant ataxin-7 in neurons and abnormalities in short-term plasticity.
Yoo SY; Pennesi ME; Weeber EJ; Xu B; Atkinson R; Chen S; Armstrong DL; Wu SM; Sweatt JD; Zoghbi HY
Neuron; 2003 Feb; 37(3):383-401. PubMed ID: 12575948
[TBL] [Abstract][Full Text] [Related]
17. SCA7 mouse models show selective stabilization of mutant ataxin-7 and similar cellular responses in different neuronal cell types.
Yvert G; Lindenberg KS; Devys D; Helmlinger D; Landwehrmeyer GB; Mandel JL
Hum Mol Genet; 2001 Aug; 10(16):1679-92. PubMed ID: 11487572
[TBL] [Abstract][Full Text] [Related]
18. Proteolytic cleavage of ataxin-7 promotes SCA7 retinal degeneration and neurological dysfunction.
Guyenet SJ; Mookerjee SS; Lin A; Custer SK; Chen SF; Sopher BL; La Spada AR; Ellerby LM
Hum Mol Genet; 2015 Jul; 24(14):3908-17. PubMed ID: 25859008
[TBL] [Abstract][Full Text] [Related]
19. Spinocerebellar ataxia type 7 associated with pigmentary retinal dystrophy.
Michalik A; Martin JJ; Van Broeckhoven C
Eur J Hum Genet; 2004 Jan; 12(1):2-15. PubMed ID: 14571264
[TBL] [Abstract][Full Text] [Related]
20. Toward cell specificity in SCA1.
Humbert S; Saudou F
Neuron; 2002 May; 34(5):669-70. PubMed ID: 12062012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
